27. Dezember 2026
FDA PDUFA target action date for MR-107A-02 (fast-acting meloxicam), a NDA from Viatris. This is the date by which the FDA is due to act on the application; it can be extended or the decision can come earlier.
FDA-PDUFA-Entscheidungstermine-Kalender